Haemdall: Developing a Quantitative MRI Biomarker of Infratentorial Superficial Siderosis of the Central Nervous System

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-08-14

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Haemdall: Using Medical Imaging to measure Brain Iron in Superficial Siderosis.

This study is looking at a new way of using MRI scans to potentially measure the amount of iron on the surface of the brain. Iron build up in the brain is linked to how superficial siderosis develops. The study will also aim to see if there is a connection between the amount of iron in the brain and common superficial siderosis symptoms. Clinical tests will be used to measure symptoms including tests to measure your hearing, walking \& balance and participants' ability to remember, think and understand.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Non-Heme Iron Load Quantification in the Brain - MRI of Patients With Stroke

NCT01829386

Stroke

COMPLETED

Brain Iron Toxicity and Neurodegeneration - A 7T MRI Study

NCT04992975

Prodromal Alzheimer's Disease Mild Cognitive Impairment

RECRUITING

Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease

NCT00249080

Neurodegenerative Diseases Mild Cognitive Impairment

COMPLETED

MRI for the Early Evaluation of Acute Intracerebral Hemorrhage

NCT01689402

Cerebral Hemorrhage Intracranial Arteriovenous Malformations Intracranial Hemorrhage, Hypertensive +1 more

COMPLETED

Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome

NCT02083367

Hepatic Encephalopathy Cirrhosis Nonalcoholic Steatohepatitis +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Superficial Siderosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Superficial siderosis cohort

Individuals diagnosed with infratentorial superficial siderosis

No interventions assigned to this group

Healthy volunteer cohort

Healthy volunteers without other neurological condition or significant disease

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Superficial siderosis cohort:

* Male or female adults of 18 years of age or older with a confirmed diagnosis of superficial siderosis
* Participants who have the capacity and a level of English proficiency that allows him/her to communicate well with the Investigator, understand and comply with the requirements of the investigation, read all participant facing documentation, as well as read and sign the informed consent form.
* Participants willing and able to give informed consent for participation in the investigation

Healthy cohort:

* Male or female over 18 years of age without a diagnosis of a neurological disorder
* Participants who have the capacity and a level of English proficiency that allows him/her to communicate well with the Investigator, understand and comply with the requirements of the investigation, read all participant facing documentation, as well as read and sign the informed consent form.
* Participants willing and able to give informed consent for participation in the investigation

Exclusion Criteria

* The participant may not enter the investigation if they have any contraindication to magnetic resonance imaging (including pregnancy, extensive tattoos, pacemaker, shrapnel injury or metallic unfixed implanted devices, metallic fragments, severe claustrophobia and cochlear implants)
* Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the investigation, or may influence the result of the investigation, or the participant's ability to participate in the investigation
* Participants who do not demonstrate the capacity to understand the investigation information or provide informed consent

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes